{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:59:35Z","timestamp":1783036775808,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:00:00Z","timestamp":1530316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bjid.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T08:32:04Z","timestamp":1531902724000},"page":"323-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Microbiology and clinical characteristics of viridans group streptococci in patients with cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Fuensanta","family":"Guerrero-Del-Cueto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyntia","family":"Ibanes-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Vel\u00e1zquez-Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cornejo-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-8372","authenticated-orcid":false,"given":"Diana","family":"Vilar-Compte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2018.06.003_bib0005","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","article-title":"Infections caused by viridans streptococci in patients with neutropenia","volume":"34","author":"Tunkel","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2018.06.003_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/cid\/ciu264","article-title":"Editorial commentary: viridans group streptococci in febrile neutropenic cancer patients: What should we fear?","author":"Freifeld","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2018.06.003_bib0015","doi-asserted-by":"crossref","first-page":"e0120502","DOI":"10.1371\/journal.pone.0120502","article-title":"Viridans group streptococci clinical isolates: MALDI-TOF mass spectrometry versus gene sequence-based identification","volume":"10","author":"Angeletti","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bjid.2018.06.003_bib0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1469-0691.2012.03837.x","article-title":"Value of matrix-assisted laser desorption ionization-time of flight for routine identification of viridans group streptococci causing bloodstream infections","volume":"19","author":"L\u00f3pez Roa","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2018.06.003_bib0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/cid\/cir523","article-title":"Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review","volume":"53","author":"Tomlinson","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2018.06.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/561020","article-title":"Aetiology of bacteraemia as a risk factor for septic shock at the onset of febrile neutropaenia in adult cancer patients","volume":"2014","author":"Rosa","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.bjid.2018.06.003_bib0035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3201\/eid2005.130953","article-title":"Streptococcus mitis strains causing severe clinical disease in cancer patients","volume":"20","author":"Shelburne","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bjid.2018.06.003_bib0040","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1099\/jmm.0.076653-0","article-title":"Identification of the \u2018Streptococcus anginosus group\u2019 by matrix-assisted laser desorption ionization \u2013 time-of-flight mass spectrometry","volume":"63","author":"Woods","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.bjid.2018.06.003_bib0045","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2018.06.003_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/JCM.44.1.160-165.2006","article-title":"Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases","volume":"44","author":"Han","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"42","key":"10.1016\/j.bjid.2018.06.003_bib0055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ajic.2014.06.012","article-title":"Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer","author":"Shelburne","year":"2014","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.bjid.2018.06.003_bib0060","series-title":"Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and non-central line-associated Bloodstream Infection)","first-page":"1","author":"Centers for Disease Control","year":"2017"},{"key":"10.1016\/j.bjid.2018.06.003_bib0065","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2018.06.003_bib0070","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/317460","article-title":"Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.","volume":"31","author":"Marron","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2018.06.003_bib0075","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s10096-012-1589-7","article-title":"Milleri group streptococcus \u2013 a stepchild in the viridans family","volume":"31","author":"Siegman-Igra","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2018.06.003_bib0080","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1099\/jmm.0.000176","article-title":"Clinical and microbiological outcomes in patients with Streptococcus anginosus group bacteraemia identified through use of a rapid microarray assay","volume":"64","author":"Wenzler","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.bjid.2018.06.003_bib0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/CMR.15.4.613-630.2002","article-title":"What happened to the streptococci: overview of taxonomic and nomenclature changes","volume":"15","author":"Facklam","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bjid.2018.06.003_bib0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cid\/ciu260","article-title":"Development and validation of a clinical model to predict the presence of B-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients","volume":"59","author":"Shelburne","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867018301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867018301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T19:22:05Z","timestamp":1538421725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867018301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1413867018301326"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2018.06.003","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiology and clinical characteristics of viridans group streptococci in patients with cancer","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}